Stryker Total Current Liabilities 2010-2024 | SYK

Stryker total current liabilities from 2010 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
  • Stryker total current liabilities for the quarter ending September 30, 2024 were $7.669B, a 2.83% increase year-over-year.
  • Stryker total current liabilities for 2023 were $7.921B, a 25.67% increase from 2022.
  • Stryker total current liabilities for 2022 were $6.303B, a 38.56% increase from 2021.
  • Stryker total current liabilities for 2021 were $4.549B, a 9.76% decline from 2020.
Stryker Annual Total Current Liabilities
(Millions of US $)
2023 $7,921
2022 $6,303
2021 $4,549
2020 $5,041
2019 $4,400
2018 $4,807
2017 $3,485
2016 $3,148
2015 $3,502
2014 $4,461
2013 $2,657
2012 $1,876
2011 $1,840
2010 $1,605
2009 $1,441
Stryker Quarterly Total Current Liabilities
(Millions of US $)
2024-09-30 $7,669
2024-06-30 $6,926
2024-03-31 $6,955
2023-12-31 $7,921
2023-09-30 $7,458
2023-06-30 $6,584
2023-03-31 $5,866
2022-12-31 $6,303
2022-09-30 $4,571
2022-06-30 $4,404
2022-03-31 $4,408
2021-12-31 $4,549
2021-09-30 $4,449
2021-06-30 $4,252
2021-03-31 $3,953
2020-12-31 $5,041
2020-09-30 $4,689
2020-06-30 $4,405
2020-03-31 $4,162
2019-12-31 $4,400
2019-09-30 $3,921
2019-06-30 $3,946
2019-03-31 $3,713
2018-12-31 $4,807
2018-09-30 $4,153
2018-06-30 $4,046
2018-03-31 $4,800
2017-12-31 $3,485
2017-09-30 $3,258
2017-06-30 $3,552
2017-03-31 $2,554
2016-12-31 $3,148
2016-09-30 $3,026
2016-06-30 $3,605
2016-03-31 $3,186
2015-12-31 $3,502
2015-09-30 $3,553
2015-06-30 $3,723
2015-03-31 $3,695
2014-12-31 $4,461
2014-09-30 $4,211
2014-06-30 $3,713
2014-03-31 $3,558
2013-12-31 $2,657
2013-09-30 $2,324
2013-06-30 $1,971
2013-03-31 $1,808
2012-12-31 $1,876
2012-09-30 $1,576
2012-06-30 $1,489
2012-03-31 $1,549
2011-12-31 $1,840
2011-09-30 $1,562
2011-06-30 $1,604
2011-03-31 $1,587
2010-12-31 $1,605
2010-09-30 $1,406
2010-06-30 $1,295
2010-03-31 $1,405
2009-12-31 $1,441
2009-09-30 $1,198
2009-06-30 $1,075
2009-03-31 $1,182
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $148.171B $20.498B
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $203.157B 25.91
Boston Scientific (BSX) United States $133.131B 38.28
EssilorLuxottica (ESLOY) France $113.461B 0.00
Medtronic (MDT) Ireland $109.010B 16.19
Haleon (HLN) United Kingdom $42.913B 27.88
Lonza Group Ag (LZAGY) Switzerland $42.122B 0.00
GE HealthCare Technologies (GEHC) United States $37.701B 19.56
ResMed (RMD) United States $34.955B 28.72
Terumo (TRUMY) Japan $29.203B 41.24
Koninklijke Philips (PHG) Netherlands $24.410B 18.68
Zimmer Biomet Holdings (ZBH) United States $22.087B 14.06
Insulet (PODD) United States $18.377B 73.18
Baxter (BAX) United States $16.604B 10.80
Smith & Nephew SNATS (SNN) United Kingdom $11.153B 0.00
BellRing Brands (BRBR) United States $9.468B 37.96
Bio-Rad Laboratories (BIO) United States $8.977B 30.51
Demant (WILYY) Denmark $8.342B 0.00
Lantheus Holdings (LNTH) United States $5.523B 12.83
TG Therapeutics (TGTX) United States $4.720B 0.00
Haemonetics (HAE) United States $4.260B 20.79
ICU Medical (ICUI) United States $4.155B 39.56
Prestige Consumer Healthcare (PBH) United States $4.074B 20.26
Perrigo (PRGO) Ireland $3.716B 10.94
Envista Holdings (NVST) United States $3.487B 25.97
Neogen (NEOG) United States $3.270B 37.72
Agios Pharmaceuticals (AGIO) United States $3.103B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
GN Store Nord (GNNDY) Denmark $2.789B 17.89
QuidelOrtho (QDEL) United States $2.595B 16.70
Warby Parker (WRBY) United States $2.344B 0.00
LeMaitre Vascular (LMAT) United States $2.332B 56.69
Green Thumb Industries (GTBIF) United States $1.964B 34.37
AtriCure (ATRC) United States $1.772B 0.00
InMode (INMD) Israel $1.487B 8.94
Curaleaf Holdings (CURLF) Canada $1.348B 0.00
AdaptHealth (AHCO) United States $1.311B 9.37
Maravai LifeSciences Holdings (MRVI) United States $1.168B 0.00
BioLife Solutions (BLFS) United States $1.041B 0.00
Phibro Animal Health (PAHC) United States $0.962B 16.96
Owens & Minor (OMI) United States $0.957B 7.48
CeriBell (CBLL) United States $0.916B 0.00
National Vision Holdings (EYE) United States $0.888B 29.68
Capricor Therapeutics (CAPR) United States $0.839B 0.00
Evolus (EOLS) United States $0.785B 0.00
Verano Holdings (VRNOF) United States $0.608B 0.00
Cresco Labs (CRLBF) United States $0.596B 0.00
VAREX IMAGING (VREX) United States $0.596B 26.47
Surmodics (SRDX) United States $0.559B 0.00
Quanterix (QTRX) United States $0.424B 0.00
Canopy Growth (CGC) Canada $0.404B 0.00
Valneva SE (VALN) France $0.370B 0.00
ZimVie (ZIMV) United States $0.363B 30.63
Omeros (OMER) United States $0.349B 0.00
Viemed Healthcare (VMD) United States $0.335B 31.89
Biote (BTMD) United States $0.330B 7.25
Sanara MedTech (SMTI) United States $0.323B 0.00
Cerus (CERS) United States $0.312B 0.00
OraSure Technologies (OSUR) United States $0.288B 19.30
Zynex (ZYXI) United States $0.249B 52.13
TerrAscend (TSNDF) Canada $0.243B 0.00
Aurora Cannabis (ACB) Canada $0.229B 0.00
Utah Medical Products (UTMD) United States $0.219B 15.15
MacroGenics (MGNX) United States $0.218B 0.00
High Tide (HITI) Canada $0.215B 89.00
Sanuwave Health (SNWV) United States $0.195B 2.74
Jin Medical (ZJYL) China $0.188B 0.00
Zevia PBC (ZVIA) United States $0.162B 0.00
Brainsway (BWAY) Israel $0.161B 96.70
Organigram Holdings (OGI) Canada $0.158B 0.00
FitLife Brands (FTLF) United States $0.143B 17.98
TriSalus Life Sciences (TLSI) United States $0.126B 0.00
Quipt Home Medical (QIPT) United States $0.106B 0.00
Fonar (FONR) United States $0.093B 10.54
Oramed Pharmaceuticals (ORMP) United States $0.093B 23.00
Veru (VERU) United States $0.092B 0.00
Ayr Wellness (AYRWF) United States $0.082B 0.00
Rockwell Medical (RMTI) United States $0.080B 41.50
Modular Medical (MODD) United States $0.073B 0.00
Jushi Holdings (JUSHF) United States $0.070B 0.00
Cellectar Biosciences (CLRB) United States $0.066B 0.00
InterCure (INCR) Israel $0.063B 0.00
Exagen (XGN) United States $0.062B 0.00
MariMed (MRMD) United States $0.059B 0.00
Safety Shot (SHOT) United States $0.056B 0.00
Cytosorbents (CTSO) United States $0.052B 0.00
Apyx Medical (APYX) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.032B 0.00
Allurion Technologies (ALUR) United States $0.026B 0.00
Flora Growth (FLGC) United States $0.018B 0.00
Nephros (NEPH) United States $0.016B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.011B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Agape ATP (ATPC) $0.006B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.001B 0.00
Senestech (SNES) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 13.17
SNDL (SNDL) Canada $0.000B 0.00